The efficacy of statins in the treatment of Alzheimer ’s disease: a meta-analysis of randomized controlled trial

ConclusionStatins used in AD patients had beneficial effects on the scores of MMSE scale in the short term ( ≤ 12 months), and statins could slow the deterioration of neuropsychiatric status and significantly improve activities of daily living ability in AD patients, but statins did not show an advantage in the change of the ADAS-Cog scale scores.
Source: Neurological Sciences - Category: Neurology Source Type: research